The Current and Future Status of Pacritinib: An Expert Explains - 100038

Spotlight
Video

The Current and Future Status of Pacritinib: An Expert Explains

patientpower has 2417 videos Subscribe Here

Loading........
Description: Over the past year, the investigational oral kinase inhibitor, pacritinib, has been making headlines. In Feb 2016, the FDA put a clinical hold on the trial. Just a few months later, the FDA allowed some patients to re-enter the trial as part of a compassionate use program. Now, in January of 2017, the full clinical hold has been removed. To help patients sort through the information and to update us on the status of pacritinib, Dr. John Mascarenhas joined us from Mount Sinai Medical Center in New York City.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://www.youtube.com/pati...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...
Follow on Google+ | http://www.google.com/+pati...
Shared By : patientpower
Posted on : 01/27/17
Added : 1 year ago



Recommended

Nothing found.